MedPath

The clinical study for evaluating the early efficacy and safty of alpha-1-adrenoreceptor antagonists in patient with benign prostatic hyperplasia.

Not Applicable
Conditions
Benign prostatic hyperplasia (BPH)
Registration Number
JPRN-UMIN000005151
Lead Sponsor
Department of Renal and Urologic Surgery, Asahikawa Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1. residual volume>=50ml 2. cases with prostate cancer, bladder cancer or interstitial cystitis 3. cases with urethral stricture 4. cases with complications which may affect the lower urinary tract symptoms such as diabetes mellitus, cerebrovascular disease and spinal cord injury

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath